Clinical trials
Terminated Phase 4 Psychotic Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 3 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Duke University | 2 |
| UMC Utrecht | 2 |
| AstraZeneca | 1 |
| Dartmouth-Hitchcock Medical Center | 1 |
| David C. Henderson, MD | 1 |
| Northwell Health | 1 |
| Northwestern University | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
| Seattle Institute for Biomedical and Clinical Research | 1 |
| University of California, Los Angeles | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Psychotic Disorders | 14 |
| Schizophrenia | 13 |
| Alcoholism | 1 |
| Antisocial Personality Disorder | 1 |
| Disruptive, Impulse Control, and Conduct Disorders | 1 |
| Hyperprolactinemia | 1 |
| Mental Disorders | 1 |
| Metabolic Syndrome | 1 |
| Obesity | 1 |
| Overweight | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.